Overview of Sinaloa’s Success in National Vaccination Week 2025
Sinaloa, a state in Mexico, has been recognized as the leading entity in the country for its exceptional vaccination coverage during the National Vaccination Week 2025. The Secretary of Health, Dr. Cuitláhuac González Galindo, proudly announced that Sinaloa has surpassed the 100% vaccination target, achieving a remarkable 340% coverage.
Background on Sinaloa and its Health Initiatives
Situated in northwestern Mexico, Sinaloa is known for its rich cultural heritage and diverse landscapes. The state has a population of approximately 3.5 million people, making its successful vaccination campaign even more significant. Dr. Cuitláhuac González Galindo, the Secretary of Health, has been instrumental in driving health initiatives and ensuring the well-being of Sinaloa’s residents.
National Vaccination Week 2025 Achievements
During the National Vaccination Week 2025, Sinaloa administered a total of 160,141 doses, targeting various age groups and high-risk populations. The campaign aimed to protect the population against preventable viruses and diseases through immunization.
Key Figures and Sources
- Ramiro López Elizalde: Subsecretary of Prevention and Health Promotion, who presented the data during La Mañanera del Pueblo, a morning conference hosted by Presidenta Claudia Sheinbaum.
- Dr. Cuitláhuac González Galindo: Secretary of Health for Sinaloa, who confirmed the state’s leading position in vaccination coverage.
Vaccination Targets and Recipient Groups
The National Vaccination Week 2025 focused on protecting the following groups:
- Children under one year and up to nine years old
- Adolescents
- Adults aged 20 to 59
- Individuals over 60 years old
- Pregnant women from week 20 of gestation
- Healthcare professionals
Vaccines Administered and Their Importance
During this campaign, several vaccines were administered to safeguard the population against various diseases:
- Measles
- Rubella
- Whooping cough (pertussis)
- Tetanus
- Hepatitis B
- Diphtheria
- Pneumococcal disease
- DTaP (Diphtheria, Tetanus, Pertussis)
- MMR (Measles, Mumps, Rubella)
- HPV (Human Papillomavirus)
The HPV vaccine was specifically targeted at girls in fifth grade or boys and girls aged 11 who were not enrolled in school.
Continued Access to Vaccines
Dr. Cuitláhuac González Galindo emphasized that all these vaccines will remain accessible in healthcare facilities for those who have not yet received them. This ensures that Sinaloa’s residents can continue to benefit from the state’s successful vaccination efforts.
Key Questions and Answers
- What is the significance of Sinaloa leading in vaccination coverage? Sinaloa’s success demonstrates the state’s commitment to public health and sets an example for other entities in Mexico.
- Which age groups were prioritized during the National Vaccination Week 2025? The campaign targeted children under one year and up to nine years old, adolescents, adults aged 20 to 59, individuals over 60, pregnant women from week 20 of gestation, and healthcare professionals.
- What diseases were the vaccines intended to protect against? The vaccines protected against measles, rubella, whooping cough, tetanus, hepatitis B, diphtheria, pneumococcal disease, pertussis, DTaP (Diphtheria, Tetanus, Pertussis), MMR (Measles, Mumps, Rubella), and HPV (Human Papillomavirus).
- Will vaccines remain accessible for those who haven’t received them yet? Yes, all vaccines will continue to be available in healthcare facilities for anyone who needs them.
